Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image15th July 2024 Vol. No. 13 ; Issue No.639
Publications

1. Gaikwad S, Trivedi B, Gholap S(2024). Unilateral arm weakness following retroperitoneal lymph node dissection for testicular germ cell tumour. Anaesthesia Reports. 12(2):e12312.

2. Noronha V, Budukh A, Chaturvedi P, Anne S, Punjabi A, Bhaskar M, Sahoo T, Menon N, Shah M, Batra U, Nathany S, Kumar R, Shetty O, Ghodke T, Mahajan A, Chakrabarty N, Hait S, Tripathi S, Chougule A, Chandrani P, Tripathi VK, Jiwnani S, Tibdewal A, Maheshwari G, Kothari R, Patil V, Bhat R, Khanderia M, Mahajan V, Prakash R, Sharma S, Jabbar A, Yadav BK, Uddin AFM, Dutt A, Prabhash K (2024). Uniqueness of lung cancer in Southeast Asia. The Lancet Regional Health - Southeast Asia.

Theses
1. Neha Mishra. 2024. Structural and functional characterization of different domains of BRCA1 and its interacting proteins. (LIFE09201704016)(Guide: Dr. Ashok Varma).

2. Joel Parasottam Christie. 2024. Quantitative proteomic approach to characterize the functions and the regulatory role of proteasomal assembly chaperones. (LIFE09201504002) (Guide: Dr. Prasanna Venkatraman)

Site of the Week

ProteomicsDB is dedicated to expedite the identification of various proteomes and their use across the scientific community.

desktop Image
Interesting Reads

Chen H, Li Y, Li H, Chen X, Fu H, Mao D, Chen W, Lan L, Wang C, Hu K, Li J, Zhu C, Evans I, Cheung E, Lu D, He Y, Behrens A, Yin D, Zhang C (2024). NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature.

Video of the Week
CAR T-Cell Therapy Development in India
Upcoming Events
TMC HEAD & NECK REHABCON 2024 (Tata Memorial Centre Rehabilitation Conference)

31st August, 2024

At  ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

1st Genomic Workshop on Next Generation Sequencing and Bioinformatics

September 24-28, 2024

At  ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

9th International Conference on Cancer Research & Drug Development

November 18-20, 2024

At Boston, USA

Do You Know?

In 2019, It was observed that targeted therapy Ribociclib added to endocrine therapy improves survival in young women with certain types of breast cancers.

back Image
Cancer News
Lorlatinib slows growth of ALK-positive lung cancers, may prevent brain metastases.

National Cancer Institute, 12/07/2024

The drug lorlatinib (Lorbrena) is superior to crizotinib (Xalkori) as an initial treatment for people with advanced non-small cell lung cancer (NSCLC) that has changes in the ALK gene, according to new results from a global clinical trial...

New discovery suggests opportunity to improve effectiveness of KRAS inhibitors against pancreatic cancer

MedicalXpress, 11/07/2024

Mutations in the KRAS gene are the primary driver of pancreatic cancer. A new class of drugs known as KRAS inhibitors is showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment...

Immunotherapy approach shows potential in some people with metastatic solid tumors.

EurekAlert, 11/07/2024

The new approach overcomes two challenges in cellular immunotherapy: how to produce large numbers of T cells that can recognize cancer cells specifically, and how to boost the ability of modified T cells to multiply once they’ve been returned to the patient...

2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)